{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:27:46Z","timestamp":1738387666320,"version":"3.35.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.ejphar.2008.08.014","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T09:28:13Z","timestamp":1220002093000},"page":"32-40","source":"Crossref","is-referenced-by-count":8,"title":["The antagonistic effect of antipsychotic drugs on a HEK293 cell line stably expressing human \u03b11A1-adrenoceptors"],"prefix":"10.1016","volume":"596","author":[{"given":"Zahra","family":"Nourian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Mulvany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten Bork","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl S.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.08.014_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002280050067","article-title":"The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin","volume":"50","author":"Andros","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib2","first-page":"48","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshano","year":"1959","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1192\/S0007125000298097","article-title":"Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics","author":"Barnes","year":"1999","journal-title":"Br. J. Psychiatr., Suppl."},{"key":"10.1016\/j.ejphar.2008.08.014_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00002018-200023030-00004","article-title":"Cardiovascular adverse effects of antipsychotic drugs","volume":"23","author":"Buckley","year":"2000","journal-title":"Drug Safety"},{"key":"10.1016\/j.ejphar.2008.08.014_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00213-003-1639-z","article-title":"Differential region-specific regulation of central alpha 1-adrenoceptor binding following chronic haloperidol and clozapine administration in the rat","volume":"172","author":"Cahir","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.08.014_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-5793(98)00024-6","article-title":"Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoforms","volume":"422","author":"Chang","year":"1998","journal-title":"FEBS Letters"},{"key":"10.1016\/j.ejphar.2008.08.014_bib7","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1074\/jbc.M508651200","article-title":"Syntrophins regulate alpha1D-adrenergic receptors through a PDZ domain-mediated interaction","volume":"281","author":"Chen","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Pt 1","key":"10.1016\/j.ejphar.2008.08.014_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/0264-6021:3430231","article-title":"Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors","volume":"343","author":"Coge","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2008.08.014_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3565(24)37609-8","article-title":"Crosstalk between alpha-1A and alpha-1B adrenoceptors in neonatal rat myocardium: implications in cardiac hypertrophy","volume":"286","author":"Deng","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.08.014_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00213-003-1576-x","article-title":"Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine","volume":"171","author":"Goudie","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.08.014_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.RES.78.5.737","article-title":"Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling","volume":"78","author":"Graham","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.08.014_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tips.2004.06.011","article-title":"Update on human alpha1-adrenoceptor subtype signaling and genomic organization","volume":"25","author":"Hawrylyshyn","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.08.014_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0031-6997(25)06845-0","article-title":"International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update","volume":"47","author":"Hieble","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2008.08.014_bib14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1006\/bbrc.1993.2130","article-title":"Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor","volume":"195","author":"Hirasawa","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2008.08.014_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0014-5793(95)00330-C","article-title":"Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants","volume":"363","author":"Hirasawa","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2008.08.014_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-2999(97)01242-9","article-title":"The antipsychotic drug sertindole is a specific inhibitor of alpha1A-adrenoceptors in rat mesenteric small arteries","volume":"336","author":"Ipsen","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0022-3565(24)29283-1","article-title":"Functional characterization of alpha1-adrenoceptor subtypes in human subcutaneous resistance arteries","volume":"299","author":"Jarajapu","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.08.014_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0165-6147(99)01355-3","article-title":"7TM receptors: the splicing on the cake","volume":"20","author":"Kilpatrick","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.08.014_bib19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0006-8993(88)90390-3","article-title":"Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry","volume":"460","author":"Lane","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2008.08.014_bib20","doi-asserted-by":"crossref","first-page":"22887","DOI":"10.1016\/S0021-9258(17)31728-3","article-title":"Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor","volume":"269","author":"Lattion","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.08.014_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0165-6147(98)01186-9","article-title":"The cerebral cortex: a case for a common site of action of antipsychotics","volume":"19","author":"Lidow","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2008.08.014_bib22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2008.08.014_bib23","first-page":"S6","article-title":"Orthostatic hypotension: causes, mechanisms, and influencing factors","volume":"45","author":"Mathias","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2008.08.014_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0163-7258(00)00092-9","article-title":"Alpha 1-adrenergic receptor regulation: basic science and clinical implications","volume":"88","author":"Michelotti","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2008.08.014_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s002130100820","article-title":"Autonomic responses of blood vessels and sweat glands in patients with schizophrenia treated with olanzapine or clozapine","volume":"157","author":"Mueck-Weymann","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.08.014_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(00)00136-9","article-title":"Effects of chronic risperidone on central noradrenergic transmission","volume":"394","author":"Nasif","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-2999(98)00668-2","article-title":"Pharmacological properties of homomeric and heteromeric GluR1o and GluR3o receptors","volume":"360","author":"Nielsen","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-007-1064-9","article-title":"Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha(1)-adrenoceptor function","volume":"199","author":"Nourian","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.08.014_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2710.2005.00629.x","article-title":"High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans","volume":"30","author":"Poon","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejphar.2008.08.014_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(94)90041-8","article-title":"Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine","volume":"262","author":"Prinssen","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2008.08.014_bib32","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.100.23.2336","article-title":"Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age","volume":"100","author":"Rudner","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.08.014_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2008.08.014_bib35","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1016\/S0021-9258(19)39055-6","article-title":"Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype","volume":"265","author":"Schwinn","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.08.014_bib36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-3565(25)24297-5","article-title":"Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues","volume":"272","author":"Schwinn","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.08.014_bib37","first-page":"459","article-title":"Postural hypotension in chronically medicated schizophrenics","volume":"51","author":"Silver","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2008.08.014_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00004714-199710000-00011","article-title":"Two rapid-dose titrations of sertindole in patients with schizophrenia","volume":"17","author":"Sramek","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1248\/bpb.22.457","article-title":"A rabbit model for evaluation of chlorpromazine-induced orthostatic hypotension","volume":"22","author":"Takata","year":"1999","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2008.08.014_bib40","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s007020070036","article-title":"Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats","volume":"107","author":"Wadenberg","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2008.08.014_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0022-5347(01)61986-4","article-title":"Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate","volume":"161","author":"Walden","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2008.08.014_bib42","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1006\/bbrc.1994.1845","article-title":"Cloning, expression and characterization of human alpha adrenergic receptors alpha 1a, alpha 1b and alpha 1c","volume":"201","author":"Weinberg","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908008868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908008868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:42:42Z","timestamp":1738348962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908008868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":42,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0014299908008868"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.08.014","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}